Home › NDC Lookup › RxCUI directory › RxCUI 1373463

Canagliflozin 100 MG Oral Tablet — RxCUI 1373463

Name: Canagliflozin 100 MG Oral Tablet (RxCUI 1373463)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1373463 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 14 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1373463

Official nameCanagliflozin 100 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known ascanagliflozin (as canagliflozin hemihydrate) 100 MG Oral Tablet

FDA products mapped5

Package NDCs mapped14

Reported Medicaid activity (SDUD)60,010 prescriptions · 44 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Canagliflozin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Invokana helps lower your blood sugar by making your kidneys pass extra glucose out in your urine rather than keeping it in your blood. On top of that, if you also have heart disea...
What exactly is Invokana supposed to do for me if I have type 2 diabetes?
This is a real risk worth knowing about. In large clinical trials, people taking Invokana had about twice the rate of lower limb amputations compared to those on placebo — most com...
I heard Invokana can cause amputations. How worried should I be?

📖 Read our full Canagliflozin guide →

🕸️ Concept Web — How Canagliflozin 100 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Canagliflozin 100 MG Oral Tablet RxCUI 1373463 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Canagliflozin 1373458 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Invokana 1373464 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Canagliflozin Oral Tablet 1373462 SCDF
- Canagliflozin Oral Product 1373460 SCDG
- Canagliflozin Pill 1373461 SCDG
- Canagliflozin Oral Tablet [Invokana] 1373466 SBDF
- Invokana Oral Product 1373467 SBDG
- Invokana Pill 1373468 SBDG
- Oral Tablet 317541 DF
- Oral Product 1151131 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Canagliflozin 100 MG 1373459 SCDC
- Canagliflozin 100 MG Oral Tablet [Invokana] 1373469 SBD
- Canagliflozin 100 MG [Invokana] 1373465 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Canagliflozin 100 MG SCDC · 1373459
Canagliflozin Oral Tablet SCDF · 1373462
Canagliflozin Oral Product SCDG · 1373460
Canagliflozin Pill SCDG · 1373461

Brand-Name Concepts

Canagliflozin 100 MG Oral Tablet [Invokana] SBD · 1373469
Canagliflozin 100 MG [Invokana] SBDC · 1373465
Canagliflozin Oral Tablet [Invokana] SBDF · 1373466
Invokana Oral Product SBDG · 1373467
Invokana Pill SBDG · 1373468
Invokana BN · 1373464

📦 FDA Products & Package NDCs

5 products · 14 package NDCs

14 package NDCs map to RxCUI 1373463 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
50090-5034-00	90 TABLET, FILM COATED in 1 BOTTLE (50090-5034-0)	INVOKANA	A-S Medication Solutions	2020-05-04
50090-5034-01	30 TABLET, FILM COATED in 1 BOTTLE (50090-5034-1)	INVOKANA	A-S Medication Solutions	2020-05-05
50458-0140-01	5 TABLET, FILM COATED in 1 BOTTLE (50458-140-01)	INVOKANA	Janssen Pharmaceuticals, Inc.	2013-03-29
50458-0140-10	10 BLISTER PACK in 1 CARTON (50458-140-10) / 10 TABLET, FIL...	INVOKANA	Janssen Pharmaceuticals, Inc.	2013-03-29
50458-0140-30	30 TABLET, FILM COATED in 1 BOTTLE (50458-140-30)	INVOKANA	Janssen Pharmaceuticals, Inc.	2013-03-29
50458-0140-50	500 TABLET, FILM COATED in 1 BOTTLE (50458-140-50)	INVOKANA	Janssen Pharmaceuticals, Inc.	2013-03-29
50458-0140-90	90 TABLET, FILM COATED in 1 BOTTLE (50458-140-90)	INVOKANA	Janssen Pharmaceuticals, Inc.	2013-03-29
50458-0141-01	5 TABLET, FILM COATED in 1 BOTTLE (50458-141-01)	INVOKANA	Janssen Pharmaceuticals, Inc.	2013-03-29
50458-0141-10	10 BLISTER PACK in 1 CARTON (50458-141-10) / 10 TABLET, FIL...	INVOKANA	Janssen Pharmaceuticals, Inc.	2013-03-29
50458-0141-30	30 TABLET, FILM COATED in 1 BOTTLE (50458-141-30)	INVOKANA	Janssen Pharmaceuticals, Inc.	2013-03-29
50458-0141-50	500 TABLET, FILM COATED in 1 BOTTLE (50458-141-50)	INVOKANA	Janssen Pharmaceuticals, Inc.	2013-03-29
50458-0141-90	90 TABLET, FILM COATED in 1 BOTTLE (50458-141-90)	INVOKANA	Janssen Pharmaceuticals, Inc.	2013-03-29
55154-1425-08	2070 TABLET, FILM COATED in 1 BOTTLE (55154-1425-8)	INVOKANA	Cardinal Health 107, LLC	2013-03-29
55154-1426-08	720 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-1426-8)	INVOKANA	Cardinal Health 107, LLC	2013-03-29

Observed labelers: Janssen Pharmaceuticals, Inc. (10) · A-S Medication Solutions (2) · Cardinal Health 107, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.